Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 1.36 AUD Market Closed
Market Cap: 367.4m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+67%
Revenue
Forecast
+197%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

IMR Price Targets Summary
Imricor Medical Systems Inc

Wall Street analysts forecast IMR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMR is 2.26 AUD with a low forecast of 2.24 AUD and a high forecast of 2.33 AUD.

IMR Lowest Forecast
Wall Street Target
2.24 AUD
65% Upside
IMR Average Forecast
Wall Street Target
2.26 AUD
67% Upside
IMR Highest Forecast
Wall Street Target
2.33 AUD
71% Upside
Lowest
Price Target
2.24 AUD
65% Upside
Average
Price Target
2.26 AUD
67% Upside
Highest
Price Target
2.33 AUD
71% Upside
Imricor Medical Systems Inc Competitors:
Price Targets
DCTH
Delcath Systems Inc
137% Upside
6951
JEOL Ltd
39% Upside
O
OBI
Ondine Biomedical Inc
221% Upside
C
CBLL
CeriBell Inc
180% Upside
DCTH
Delcath Systems Inc
137% Upside
6951
JEOL Ltd
39% Upside
O
OBI
Ondine Biomedical Inc
221% Upside
C
CBLL
CeriBell Inc
180% Upside
OWLT
Owlet Inc
66% Upside
GN
GN Store Nord A/S
6% Upside
ALDMS
Diagnostic Medical Systems SA
47% Upside
DXR
Daxor Corp
139% Upside

Revenue
Forecast

Revenue Estimate
Imricor Medical Systems Inc

For the last 7 years the compound annual growth rate for Imricor Medical Systems Inc's revenue is 12%. The projected CAGR for the next 3 years is 197%.

12%
Past Growth
197%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Imricor Medical Systems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Imricor Medical Systems Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
What are analyst estimates?

See Also

Summary
IMR intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMR stock valuation using valuation multiples.
Wall Street Estimates
IMR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMR's stock price target?
Price Target
2.26 AUD

According to Wall Street analysts, the average 1-year price target for IMR is 2.26 AUD with a low forecast of 2.24 AUD and a high forecast of 2.33 AUD.

What is Imricor Medical Systems Inc's Revenue forecast?
Projected CAGR
197%

For the last 7 years the compound annual growth rate for Imricor Medical Systems Inc's revenue is 12%. The projected CAGR for the next 3 years is 197%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 276,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.